Figure Legends
Figure 1: Study subjects depicting inclusion and exclusion criteria.
Figure 2: Survival without ventricular arrhythmia (VA) KM curves
according to heart failure medications dose (> or ≤ median
dose), showing significantly less VA among patients taking
> median dose of beta adrenergic blockers, with no
significant impact of angiotensin antagonists or mineralocorticoid
receptor blockers medication dosages on VA occurrence. P<0.05
is considered significant.
Figure 3: Overall survival KM curves according to heart failure
medication treatment (regardless of dose) revealing reduced mortality in
patients treated with angiotensin antagonists. P<0.05 is
considered significant.
Figure 4: Survival KM curves according to presence or absence of VA, as
a time dependent covariate. Occurrence of VA had a significant impact,
increasing overall mortality. P<0.05 is considered
significant.